首页 >
法规速递
-
Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2025/12/1
2025-12-02查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第一百零二批）》（征求意见稿）意见的通知-2026/1/5
2026-01-05查看详情 > -
Document: List of signals discussed at PRAC since September 2012-2026/2/9
2026-02-10查看详情 > -
Document: Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568-2026/3/17
2026-03-18查看详情 > -
Document: Guidance on the electronic submission of information on investigational medicinal products for human use in the Extended EudraVigilance medicinal product dictionary (XEVMPD)-2026/4/20
2026-04-21查看详情 > -
Scientific guideline: Guideline on plasmid DNA vaccines for veterinary use-2023/02/24
2023-02-24查看详情 > -
关于公开征求《人纤维蛋白原临床试验技术指导原则（修订版征求意见稿）》意见的通知-2023/9/4
2023-09-05查看详情 > -
国家药监局关于废止YY/T 0771.1-2020 《动物源医疗器械 第1部分：风险管理应用》和YY/T 0771.2-2020 《动物源医疗器械 第2部分：来源、收集与处置的控制》医疗器械行业标准的公告（2024年第157号）-2025/1/6
2025-01-07查看详情 > -
Page: Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline-2025/2/6
2025-02-10查看详情 > -
Document: Frequently asked questions (FAQs): How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10-2025/3/14
2025-03-17查看详情 >
